越南作为比邻我国的东南亚发展中国家，中医药文化和产品在当地有相当的影响力，中药产品可以作为药品在越南市场销售，亦可进入当地的医疗保险，是我国中医药企业进入国际市场的首选国家和市场之一。天士力集团自2006年起进行了养血清脑颗粒在越南的申报注册，并成功取得证书。以养血清脑颗粒在越南申请处方药的过程为例，简述越南对中药处方药审评的技术要求，提出了开展中药申报的有关思路和观点，为我国中成药企业进入越南市场提供了借鉴，对于我国中成药在越南市场的拓展打下良好的基础。

Vietnam is the one of developing countries in Sout heast Asia. In Vietnam, traditional Chinese medicines (TCMs) is widely accepted in the mainstream of local pharmaceutical market, and also covered by government reimbursement. As a result, Vietnam is one of the target countries for TCM to l aunch in the market. Supported by the National Eleventh “Fiveyear” Program, Tasly has carried out studies on the application of Yangxue Qingnao Granule in V ietnam. The article has given a brief review on technical requirements of the eva luation of Chinese Proprietary Medicine and indicated relevant ideas and views o f the application as an example of prescription drug application in Vietnam. The article has provided good experience for Chinese Proprietary Medicine manufactu rers in our country to enter Vietnamese medical market, and also established the foundation for the development of Chinese Proprietary Medicine in Vietnamese market.

国家“十一五”科技支撑计划资助项目(2006BAI11B00)